Karenitecin (BNP1350) radiosensitizes glioma cells with an associated increase in caspase activation and reactive oxygen species.

by Ian Robins

Published in Journal of Neurology and Neuromedicine by Sciaccess Publishers LLC.

2017 p10-21

application/pdf 4.2 MB `file_4yhlpgeftrhknjumoqzjjlfr34`	web.archive.org (webarchive) www.jneurology.com (web)
application/pdf 4.2 MB `file_dtrznrliprcm3hn3kbpcy56oxi`	web.archive.org (webarchive) www.jneurology.com (web)

Preserved and Accessible

Type article-journal
Stage

published

Date 2017-02-01

DOI 10.29245/2572.942x/2017/2.1109

Journal Metadata
Not in DOAJ
Not in Keepers Registry
ISSN-L: 2572-942X

Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)

Cite This

BibTeX
CSL-JSON
MLA
Harvard

Lookup Links

oaDOI/unpaywall (OA fulltext)
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar

Catalog Record
Revision: 3e309987-58cc-4b2d-8776-53d0efee0b93
API URL: JSON

Karenitecin (BNP1350) radiosensitizes glioma cells with an associated increase in caspase activation and reactive oxygen species. release_swrftkxinbakpft2wzdmdx4ljy